» Articles » PMID: 32005086

An Emerging Coronavirus Causing Pneumonia Outbreak in Wuhan, China: Calling for Developing Therapeutic and Prophylactic Strategies

Overview
Date 2020 Feb 2
PMID 32005086
Citations 158
Authors
Affiliations
Soon will be listed here.
Citing Articles

SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity.

Tobias J, Steinberger P, Wilkinson J, Klais G, Kundi M, Wiedermann U Vaccines (Basel). 2024; 12(7).

PMID: 39066432 PMC: 11281395. DOI: 10.3390/vaccines12070795.


Mapping travel behavior changes during the COVID-19 lock-down: a socioeconomic analysis in Greece.

Politis I, Georgiadis G, Nikolaidou A, Kopsacheilis A, Fyrogenis I, Sdoukopoulos A Eur Transp Res Rev. 2024; 13(1):21.

PMID: 38624727 PMC: 7968570. DOI: 10.1186/s12544-021-00481-7.


Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread.

Ajmera H, Lakhawat S, Malik N, Kumar A, Bhatti J, Kumar V Curr Protein Pept Sci. 2024; 25(4):307-325.

PMID: 38265408 DOI: 10.2174/0113892037274719231212044235.


Smart stimuli-responsive drug delivery systems in spotlight of COVID-19.

Najjari Z, Sadri F, Varshosaz J Asian J Pharm Sci. 2024; 18(6):100873.

PMID: 38173712 PMC: 10762358. DOI: 10.1016/j.ajps.2023.100873.


Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.

Wu Y, Shi J, He X, Lu J, Gao X, Zhu X J Virol. 2023; 97(11):e0127923.

PMID: 37843372 PMC: 10688353. DOI: 10.1128/jvi.01279-23.


References
1.
Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

2.
Wang L, Shi W, Joyce M, Modjarrad K, Zhang Y, Leung K . Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015; 6:7712. PMC: 4525294. DOI: 10.1038/ncomms8712. View

3.
Chen Y, Lu S, Jia H, Deng Y, Zhou J, Huang B . A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg Microbes Infect. 2017; 6(5):e37. PMC: 5520482. DOI: 10.1038/emi.2017.18. View

4.
Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante C . Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet. 2004; 363(9413):938-47. PMC: 7140173. DOI: 10.1016/S0140-6736(04)15788-7. View

5.
Zhou Y, Yang Y, Huang J, Jiang S, Du L . Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain. Viruses. 2019; 11(1). PMC: 6357101. DOI: 10.3390/v11010060. View